You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 20, 2024

Details for Patent: 11,266,799


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,266,799 protect, and when does it expire?

Patent 11,266,799 protects TRUDHESA and is included in one NDA.

This patent has sixteen patent family members in thirteen countries.

Summary for Patent: 11,266,799
Title:In-line nasal delivery device
Abstract: A delivery device for a compound including: a housing, vial holding a compound; and a source of propellant, wherein the housing provides an inlet and an outlet for the vial, wherein the inlet is in fluid communication with the source of propellant and is directed against the in-line nasal delivery device compound and the outlet allows for delivery of the compound.
Inventor(s): Fuller; Christopher (Seattle, WA), Hoekman; John D. (Seattle, WA), Kohring; Craig (Seattle, WA)
Assignee: Impel Neuropharma, Inc. (Seattle, WA)
Application Number:15/759,447
Patent Claim Types:
see list of patent claims
Compound; Delivery; Device;

Drugs Protected by US Patent 11,266,799

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Jn Bidco TRUDHESA dihydroergotamine mesylate SPRAY, METERED;NASAL 213436-001 Sep 2, 2021 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 11,266,799

PCT Information
PCT FiledSeptember 09, 2016PCT Application Number:PCT/US2016/051169
PCT Publication Date:March 16, 2017PCT Publication Number: WO2017/044897

International Family Members for US Patent 11,266,799

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2016321345 ⤷  Try a Trial
Canada 2998182 ⤷  Try a Trial
China 108601916 ⤷  Try a Trial
European Patent Office 3341059 ⤷  Try a Trial
Hong Kong 1252257 ⤷  Try a Trial
Israel 257845 ⤷  Try a Trial
Japan 2018527099 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.